BioSpace News Archive

Silk Road Medical, Inc. today announced the company will be participating in a fireside chat at the upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference.

GT Biopharma, Inc. today announced third quarter 2021 results for the period ended September 30, 2021.

Pulmatrix, Inc. today reports its third quarter 2021 financial results and provides a business update.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that the company will deliver a corporate presentation during the 2021 Jefferies London Healthcare Conference -- November 16-19, 2021.

KemPharm, Inc., a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, reported its financial results for the third quarter ended September 30, 2021.

Eyenovia, Inc., a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print platform technology, announced its financial results for the third quarter ended September 30, 2021.

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today reported its financial results for the third quarter 2021.

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, reported financial results for the third quarter ended September 30, 2021.

Dyadic International, Inc., a global biotechnology company focused on further improving, applying, and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and therapeutics announced its financial results for the third quarter of 2021, and highlighted recent Company progress.

Cidara Therapeutics, Inc., a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases, reported financial results for the third quarter ended September 30, 2021 and provided an update on its corporate activities and product pipeline.